Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Shajedul Islam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4939-1001; OpenAlex author ID A5070168885. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 4 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival. Co-author DOI 10.21873/cdp.10584↗
  2. Strong Association Between Higher Expression of Anillin Actin-binding Protein in Pancreatic Adenocarcinoma Tissues and Patient Survival Analyzed With the UALCA… Co-author DOI 10.21873/cgp.20555↗
  3. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Co-author DOI 10.1038/s41598-021-90077-x↗
  4. The Expression Levels of Vinculin in Pancreatic Cancer Tissues Significantly Correlates With Patient Survival. Co-author DOI 10.21873/anticanres.15311↗
  5. Prognostic Significance of Cofilin Isoforms in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/pore.2021.1609821↗
  6. A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.3892/ol.2021.12915↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasuhiro Kuramitsu · 6 shared papers, 2021–2026 · strength 1.23
  2. Shin-Nosuke Yamashita · 2 shared papers, 2025–2026 · strength 0.52
  3. Byron Baron · 2 shared papers, 2021 · strength 0.30
  4. Yoshihiro Abiko · 1 shared paper, 2021 · strength 0.16
  5. Keisuke Kuhara · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.